Surface flattening of the human left atrium and proof-of-concept clinical applications

被引:23
|
作者
Karim, Rashed [1 ]
Ma, YingLiang [1 ]
Jang, Munjung [1 ]
Housden, R. James [1 ]
Williams, Steven E. [1 ,2 ]
Chen, Zhong [1 ,2 ]
Ataollahi, Asghar [3 ]
Althoefer, Kaspar [3 ]
Rinaldi, C. Aldo [1 ,2 ]
Razavi, Reza [1 ,2 ]
O'Neill, Mark D. [1 ,2 ]
Schaeftter, Tobias [1 ]
Rhode, Kawal S. [1 ]
机构
[1] Kings Coll London, Div Imaging Sci & Biomed Engn, London SE1 7EH, England
[2] Guys & St Thomas NHS Fdn Trust, Dept Cardiol, London SE1 7EH, England
[3] Kings Coll London, Dept Informat, Ctr Robot Res, London SE1 7EH, England
基金
英国工程与自然科学研究理事会; 英国惠康基金;
关键词
Left atrial surface parameterization; Lesion visualization; Surface flattening; Catheter ablation planning and navigation; Atrial fibrillation; CATHETER ABLATION; PARAMETERIZATION; FIBRILLATION; SEGMENTATION; MANAGEMENT; STATEMENT;
D O I
10.1016/j.compmedimag.2014.01.004
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Surface flattening in medical imaging has seen widespread use in neurology and more recently in cardiology to describe the left ventricle using the bull's-eye plot. The method is particularly useful to standardize the display of functional information derived from medical imaging and catheter-based measurements. We hypothesized that a similar approach could be possible for the more complex shape of the left atrium (LA) and that the surface flattening could be useful for the management of patients with atrial fibrillation (AF). We implemented an existing surface mesh parameterization approach to flatten and unfold 3D LA models. Mapping errors going from 2D to 3D and the inverse were investigated both qualitatively and quantitatively using synthetic data of regular shapes and computer tomography scans of an anthropomorphic phantom. Testing of the approach was carried out using data from 14 patients undergoing ablation treatment for AF. 3D LA meshes were obtained from magnetic resonance imaging and electroanatomical mapping systems. These were unfolded using the developed approach and used to demonstrate proof-of-concept applications, such as the display of scar information, electrical information and catheter position. The work carried out shows that the unfolding of complex cardiac structures, such as the LA, is feasible and has several potential clinical uses for the management of patients with AF. (C) 2014 The Authors. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:251 / 266
页数:16
相关论文
共 50 条
  • [21] Designing and conducting proof-of-concept chronic pain analgesic clinical trials
    Campbell, Claudia M.
    Gilron, Ian
    Doshi, Tina
    Raja, Srinivasa
    PAIN REPORTS, 2019, 4 (03)
  • [22] Serum biomarkers to predict clinical response in proof-of-concept trials in spondyloarthritis
    Maureen Turina
    Nataliya Yeremenko
    Jacqueline Paramarta
    Bernard Vandooren
    Paul Peter Tak
    Leen De Rycke
    Dominique Baeten
    Journal of Translational Medicine, 9 (Suppl 2)
  • [23] First clinical proof-of-concept that FMT can overcome resistance to ICIs
    Elkrief, Arielle
    Routy, Bertrand
    NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (06) : 325 - 326
  • [24] Bioimpedance method for monitoring venous ulcers: Clinical proof-of-concept study
    Kekonen, Atte
    Bergelin, Mikael
    Eriksson, Jan-Erik
    Vaalasti, Annikki
    Ylanen, Heimo
    Kielosto, Sami
    Viik, Jari
    BIOSENSORS & BIOELECTRONICS, 2021, 178
  • [25] Lenacapavir resistance analysis in a phase Ib clinical proof-of-concept study
    Margot, N.
    Ram, R.
    Parvangada, P.
    Martin, R.
    Hyland, R.
    Rhee, M.
    Callebaut, C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 9 - 10
  • [26] Serum Biomarkers to Predict Clinical Response in Proof-of-Concept Trials in Spondyloarthritis
    Turina, Maureen C.
    Yeremenko, Nataliya
    Paramarta, Jacqueline
    Vandooren, Bernard
    Tak, Paul-Peter
    De Rycke, Leen E.
    Baeten, Dominique L.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S511 - S511
  • [27] First clinical proof-of-concept that FMT can overcome resistance to ICIs
    Arielle Elkrief
    Bertrand Routy
    Nature Reviews Clinical Oncology, 2021, 18 : 325 - 326
  • [28] Phenotypic resistance to lenacapavir and monotherapy efficacy in a proof-of-concept clinical study
    Margot, Nicolas
    Vanderveen, Laurie
    Naik, Vidula
    Ram, Renee
    Parvangada, P. C.
    Martin, Ross
    Rhee, Martin
    Callebaut, Christian
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (04) : 989 - 995
  • [29] A PORTFOLIO-BASED APPROACH TO OPTIMIZE PROOF-OF-CONCEPT CLINICAL TRIALS
    Mallinckrodt, Craig
    Molenberghs, Geert
    Persinger, Charles
    Ruberg, Stephen
    Sashegyi, Andreas
    Lindborg, Stacy
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2012, 22 (03) : 596 - 607
  • [30] Lab on a chip devices for fertility: from proof-of-concept to clinical impact
    Nosrati, Reza
    LAB ON A CHIP, 2022, 22 (09) : 1680 - 1689